Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden.
Holm K, Lundgren MN, Kjeldsen-Kragh J, Ljungquist O, Böttiger B, Wikén C, Öberg J, Fernström N, Rosendal E, Överby AK, Wigren Byström J, Forsell M, Landin-Olsson M, Rasmussen M. Holm K, et al. Among authors: overby ak. BMC Res Notes. 2021 Dec 4;14(1):440. doi: 10.1186/s13104-021-05847-7. BMC Res Notes. 2021. PMID: 34863304 Free PMC article. Clinical Trial.
Large-scale phage-based screening reveals extensive pan-viral mimicry of host short linear motifs.
Mihalič F, Simonetti L, Giudice G, Sander MR, Lindqvist R, Peters MBA, Benz C, Kassa E, Badgujar D, Inturi R, Ali M, Krystkowiak I, Sayadi A, Andersson E, Aronsson H, Söderberg O, Dobritzsch D, Petsalaki E, Överby AK, Jemth P, Davey NE, Ivarsson Y. Mihalič F, et al. Among authors: overby ak. Nat Commun. 2023 Apr 26;14(1):2409. doi: 10.1038/s41467-023-38015-5. Nat Commun. 2023. PMID: 37100772 Free PMC article.
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Welén K, Överby AK, Ahlm C, Freyhult E, Robinsson D, Henningsson AJ, Stranne J, Bremell D, Angelin M, Lindquist E, Buckland R, Carlsson CT, Pauksens K, Bill-Axelsson A, Akre O, Ryden C, Wagenius M, Bjartell A, Nilsson AC, Styrke J, Repo J, Balkhed ÅÖ, Niward K, Gisslén M, Josefsson A. Welén K, et al. Among authors: overby ak. Trials. 2021 Mar 16;22(1):209. doi: 10.1186/s13063-021-05137-4. Trials. 2021. PMID: 33726804 Free PMC article.
Fluvastatin mitigates SARS-CoV-2 infection in human lung cells.
Zapatero-Belinchón FJ, Moeller R, Lasswitz L, van Ham M, Becker M, Brogden G, Rosendal E, Bi W, Carriquí-Madroñal B, Islam K, Lenman A, Gunesch AP, Kirui J, Pietschmann T, Överby AK, Jänsch L, Gerold G. Zapatero-Belinchón FJ, et al. Among authors: overby ak. iScience. 2021 Dec 17;24(12):103469. doi: 10.1016/j.isci.2021.103469. Epub 2021 Nov 18. iScience. 2021. PMID: 34812415 Free PMC article.
Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases.
Ljungquist O, Lundgren M, Iliachenko E, Månsson F, Böttiger B, Landin-Olsson M, Wikén C, Rosendal E, Överby AK, Wigren BJ, Forsell MNE, Kjeldsen-Kragh J, Rasmussen M, Kahn F, Holm K. Ljungquist O, et al. Among authors: overby ak. Infect Dis (Lond). 2022 Apr;54(4):283-291. doi: 10.1080/23744235.2021.2013528. Epub 2021 Dec 8. Infect Dis (Lond). 2022. PMID: 34878955 Free PMC article.
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data.
Welén K, Rosendal E, Gisslén M, Lenman A, Freyhult E, Fonseca-Rodríguez O, Bremell D, Stranne J, Balkhed ÅÖ, Niward K, Repo J, Robinsson D, Henningsson AJ, Styrke J, Angelin M, Lindquist E, Allard A, Becker M, Rudolfsson S, Buckland R, Carlsson CT, Bjartell A, Nilsson AC, Ahlm C, Connolly AF, Överby AK, Josefsson A. Welén K, et al. Among authors: overby ak. Eur Urol. 2022 Mar;81(3):285-293. doi: 10.1016/j.eururo.2021.12.013. Epub 2021 Dec 15. Eur Urol. 2022. PMID: 34980495 Free PMC article. Clinical Trial.
Re: Chen Dong, Sung-Lang Chen, and Wen-Wei Sung's Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93.
Welen K, Rosendal E, Freyhult E, Fors Connolly AM, Överby AK, Josefsson A. Welen K, et al. Among authors: overby ak. Eur Urol. 2022 May;81(5):e124-e125. doi: 10.1016/j.eururo.2022.02.001. Epub 2022 Feb 12. Eur Urol. 2022. PMID: 35168845 Free PMC article. No abstract available.
Reply to Carlos G. Wambier and Gerard J. Nau's Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients: Still No Positive Effect of Enzalutamide for Hospitalized COVID-19 Patients.
Welén K, Rosendal E, Freyhult E, Oh WK, Gisslén M, Ahlm C, Connolly AF, Överby AK, Josefsson A. Welén K, et al. Among authors: overby ak. Eur Urol. 2022 Jun;81(6):e143-e144. doi: 10.1016/j.eururo.2022.02.016. Epub 2022 Feb 23. Eur Urol. 2022. PMID: 35248411 Free PMC article. Clinical Trial. No abstract available.
Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections.
Rosendal E, Mihai IS, Becker M, Das D, Frängsmyr L, Persson BD, Rankin GD, Gröning R, Trygg J, Forsell M, Ankarklev J, Blomberg A, Henriksson J, Överby AK, Lenman A. Rosendal E, et al. Among authors: overby ak. mBio. 2022 Jun 28;13(3):e0089222. doi: 10.1128/mbio.00892-22. Epub 2022 May 9. mBio. 2022. PMID: 35532162 Free PMC article.
67 results